• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间歇性跛行患者的管理

Management of patients with intermittent claudication.

作者信息

Olin J W

机构信息

Vascular Medicine Programme, Mount Sinai School of Medicine, The Zena and Michael A Wiener Cardiovascular Institute, New York, NY 10029-6574, USA.

出版信息

Int J Clin Pract. 2002 Nov;56(9):687-93.

PMID:12469984
Abstract

Intermittent claudication, the most common symptomatology of peripheral arterial disease, is characterised by lower-extremity discomfort induced by exercise and relieved by rest. The most serious potential outcome of the condition is increased morbidity and mortality from cardiovascular disease, with which it is often associated, thus prompt diagnosis and management are crucial. Therapy consists of structured exercise and reduction of cardiovascular risk factors, followed by or together with pharmacological interventions with anticlaudicants (cilostazol or pentoxifylline) and specific antiplatelet agents (aspirin, clopidogrel). Revascularisation procedures are indicated in those with limb-threatening or lifestyle disabling disease.

摘要

间歇性跛行是外周动脉疾病最常见的症状,其特征是运动诱发下肢不适,休息后缓解。该疾病最严重的潜在后果是常与之相关的心血管疾病导致的发病率和死亡率增加,因此及时诊断和治疗至关重要。治疗包括有规律的运动和降低心血管危险因素,随后或同时进行使用抗跛行药物(西洛他唑或己酮可可碱)和特定抗血小板药物(阿司匹林、氯吡格雷)的药物干预。对于有肢体威胁或致残性疾病的患者,需进行血运重建手术。

相似文献

1
Management of patients with intermittent claudication.间歇性跛行患者的管理
Int J Clin Pract. 2002 Nov;56(9):687-93.
2
Management of peripheral arterial disease.外周动脉疾病的管理
Cardiol Rev. 2005 Mar-Apr;13(2):61-8. doi: 10.1097/01.crd.0000126082.86717.12.
3
Can claudication be improved with medication?
Semin Vasc Surg. 2002 Dec;15(4):237-44. doi: 10.1053/svas.2002.36259.
4
Intermittent claudication: effective medical management of a common circulatory problem.间歇性跛行:常见循环系统问题的有效药物治疗
Am J Cardiol. 2001 Jun 28;87(12A):14D-18D. doi: 10.1016/s0002-9149(01)01672-1.
5
Comparative effects of cilostazol and other therapies for intermittent claudication.西洛他唑与其他间歇性跛行治疗方法的对比效果
Am J Cardiol. 2001 Jun 28;87(12A):19D-27D. doi: 10.1016/s0002-9149(01)01673-3.
6
The role of cilostazol (Pletal) in the management of intermittent claudication.
Int J Clin Pract. 2003 Jun;57(5):405-9.
7
Cilostazol: treatment of intermittent claudication.西洛他唑:治疗间歇性跛行。
Ann Pharmacother. 2001 Jan;35(1):48-56. doi: 10.1345/aph.19408.
8
A rational approach to diagnosis and treatment of intermittent claudication.间歇性跛行诊断与治疗的合理方法。
Am J Med Sci. 2002 May;323(5):244-51. doi: 10.1097/00000441-200205000-00003.
9
Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication.外周动脉疾病的当代医学管理:关注间歇性跛行的风险降低和症状缓解。
Cardiol Clin. 2015 Feb;33(1):111-37. doi: 10.1016/j.ccl.2014.09.010.
10
Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.西洛他唑和己酮可可碱对间歇性跛行患者血管内皮生长因子的不同作用。
Clin Sci (Lond). 2001 Sep;101(3):305-11.

引用本文的文献

1
Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.外周动脉疾病。第 1 部分:临床评估与无创诊断。
Nat Rev Cardiol. 2011 May 31;8(7):405-18. doi: 10.1038/nrcardio.2011.66.